Amarantus BioScience Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMBS research report →
Companywww.amarantus.com
Amarantus BioScience Holdings, Inc. , a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis.
- CEO
- John Wesley Commissiong
- IPO
- 2010
- Employees
- 12
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $36.84K
- P/E
- -0.01
- P/S
- 0.39
- P/B
- -0.00
- EV/EBITDA
- -4.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -281.13%
- Net Margin
- -4995.23%
- ROE
- 21.36%
- ROIC
- 4.85%
Growth & Income
- Revenue
- $95.33K · 0.00%
- Net Income
- $-4,762,000 · 53.30%
- EPS
- $-0.01 · 62.56%
- Op Income
- $-268,000
- FCF YoY
- 54.68%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -12.34
- Avg Volume
- 10.82K
Get TickerSpark's AI analysis on AMBS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 12, 17 | Flanigan Conn | other | 0 |
| Feb 23, 17 | Flanigan Conn | other | 0 |
| Feb 1, 16 | COMMISSIONG GERALD | other | 45,283 |
| Apr 9, 15 | FARRELL ROBERT EDWARD | buy | 200,000 |
| Apr 8, 15 | COMMISSIONG GERALD | buy | 203,000 |
| Apr 8, 15 | COMMISSIONG GERALD | buy | 37,000 |
| Jan 12, 15 | Huffman Donald D | other | 6,490,000 |
| Nov 19, 14 | FARRELL ROBERT EDWARD | buy | 133,333 |
| Nov 20, 14 | COMMISSIONG GERALD | buy | 10,000 |
| Nov 20, 14 | COMMISSIONG GERALD | buy | 36,000 |
Our AMBS Coverage
We haven't published any research on AMBS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AMBS Report →